UU-T02 is primarily utilized in the field of biomedical research, where it serves as a potent inhibitor targeting specific cellular pathways. Its application is particularly significant in the study of cancer biology, as it effectively disrupts the signaling mechanisms that promote tumor growth and survival. Researchers employ UU-T02 to investigate the molecular basis of oncogenesis and to evaluate potential therapeutic strategies. Additionally, it is used in pharmacological studies to assess its efficacy and safety profile in preclinical models. This compound also finds utility in the development of targeted therapies, where its inhibitory properties are harnessed to design drugs that can selectively act on cancer cells while minimizing damage to healthy tissues.